Commission Implementing Regulation (EU) 2019/724 of 10 May 2019 amending Implementing Regulation (EU) No 686/2012 as regards the nomination of rapporteur Member States and co-rapporteur Member States for the active substances glyphosate, lambda-cyhalothrin, imazamox and pendimethalin and amending Implementing Regulation (EU) No 844/2012 as regards the possibility that a group of Member States assumes jointly the role of the rapporteur Member State (Text with EEA relevance.)
Commission Implementing Regulation (EU) 2019/724of 10 May 2019amending Implementing Regulation (EU) No 686/2012 as regards the nomination of rapporteur Member States and co-rapporteur Member States for the active substances glyphosate, lambda-cyhalothrin, imazamox and pendimethalin and amending Implementing Regulation (EU) No 844/2012 as regards the possibility that a group of Member States assumes jointly the role of the rapporteur Member State(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EECOJ L 309, 24.11.2009, p. 1., and in particular Article 19 thereof,Whereas:(1)Commission Implementing Regulation (EU) No 686/2012Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5). allocates the evaluation of an active substance to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluations of the active substances glyphosate, imazamox and pendimethalin have not yet been allocated to a rapporteur Member State or to a co-rapporteur Member State and their approval expires between 1 January 2022 and 31 December 2024, it is appropriate to proceed with such allocation.(2)That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.(3)In exceptional cases, the expected workload and the complexity related to the evaluation of a specific active substance might exceed the capacities of a single Member State as a rapporteur supported by a single co-rapporteur Member State. In these cases, a broader repartition of the workload and a pooling of expertise of several Member States may be warranted by designating a group of Member States acting jointly as rapporteur Member State. It should therefore be clarified that it is possible that the role of the rapporteur Member State can be assumed jointly by a group of Member States. In this case, an appointment of a co-rapporteur Member State is not needed. Accordingly, where several Member States perform jointly the role as rapporteur Member State, they should agree on the modalities of the work organisation. Against this background, the evaluation of the active substance glyphosate should be allocated to a group of Member States acting jointly as rapporteur Member State.(4)For imazamox the evaluation should be allocated to Greece as rapporteur Member State and to Italy as co-rapporteur Member State.(5)For pendimethalin the evaluation should be allocated to Sweden as rapporteur Member State and to the Netherlands as co-rapporteur Member State.(6)In agreement with the Member States concerned, it is also considered necessary to change the rapporteur Member State for the active substance lambda-cyhalothrin while respecting the balance as regards the distribution of the responsibilities and the work between Member States. The evaluation for the purposes of the renewal procedure for lambda-cyhalothrin should be allocated to Greece as rapporteur Member State, while the allocation to France as co-rapporteur remains unchanged.(7)Commission Implementing Regulation (EU) No 844/2012Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26). provides for the implementation of the renewal procedure for active substances as provided for in Regulation (EC) No 1107/2009.(8)Implementing Regulation (EU) No 844/2012 provides for the handling of applications and the subsequently submitted supplementary dossiers and their assessment by one Member State as rapporteur Member State supported by one Member State acting as co-rapporteur Member State. However, the procedural modalities should be clarified for the exceptional cases referred to above, where the evaluation is allocated to a group of Member States acting jointly as rapporteur Member State in accordance with Implementing Regulation (EU) No 686/2012. This group should jointly assume the role given to the rapporteur Member State by Implementing Regulation (EU) No 844/2012.(9)The possibilities to require fees and charges in accordance with Article 74 of Regulation (EC) No 1107/2009 should be clarified for the renewal procedure.(10)Implementing Regulations (EU) No 686/2012 and (EU) No 844/2012 should therefore be amended accordingly.(11)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,HAS ADOPTED THIS REGULATION: